Jiuliang Yan

587 total citations
18 papers, 351 citations indexed

About

Jiuliang Yan is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jiuliang Yan has authored 18 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Jiuliang Yan's work include Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Jiuliang Yan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Jiuliang Yan collaborates with scholars based in China, United States and Ethiopia. Jiuliang Yan's co-authors include Binghai Zhou, Qing‐Hai Ye, Yongfeng Xu, Yong‐Sheng Xiao, Mincheng Yu, Zheng Chen, Lei Guo, Jia Fan, Kewei Zhang and Bo Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiuliang Yan

18 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiuliang Yan China 11 139 133 113 95 73 18 351
Hechen Huang China 9 146 1.1× 210 1.6× 127 1.1× 75 0.8× 80 1.1× 11 422
Yuuki Ohara Japan 11 172 1.2× 133 1.0× 105 0.9× 67 0.7× 117 1.6× 24 396
László Márkász Sweden 10 184 1.3× 107 0.8× 121 1.1× 30 0.3× 62 0.8× 23 379
Lorena Carmona‐Rodríguez Spain 9 104 0.7× 122 0.9× 154 1.4× 82 0.9× 30 0.4× 12 345
Denis I. Trufa Germany 13 174 1.3× 155 1.2× 190 1.7× 76 0.8× 63 0.9× 21 421
Kailiang Zhao China 10 117 0.8× 182 1.4× 54 0.5× 73 0.8× 54 0.7× 38 354
Guangxi Zhao China 6 100 0.7× 136 1.0× 129 1.1× 51 0.5× 66 0.9× 8 313
Lile He China 10 94 0.7× 269 2.0× 63 0.6× 190 2.0× 40 0.5× 18 432
Xizi Dai United States 8 289 2.1× 147 1.1× 122 1.1× 67 0.7× 44 0.6× 8 389
Wenli Diao China 16 143 1.0× 345 2.6× 209 1.8× 206 2.2× 65 0.9× 29 655

Countries citing papers authored by Jiuliang Yan

Since Specialization
Citations

This map shows the geographic impact of Jiuliang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuliang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuliang Yan more than expected).

Fields of papers citing papers by Jiuliang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiuliang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuliang Yan. The network helps show where Jiuliang Yan may publish in the future.

Co-authorship network of co-authors of Jiuliang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiuliang Yan. A scholar is included among the top collaborators of Jiuliang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiuliang Yan. Jiuliang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Xie, Peiyi, Hui Wang, Bo Zhang, et al.. (2024). GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma. Oncogene. 43(42). 3108–3120. 3 indexed citations
2.
Chen, Zheng, Mincheng Yu, Bo Zhang, et al.. (2024). SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. OncoImmunology. 13(1). 2376264–2376264. 3 indexed citations
3.
4.
Hu, Beiyuan, Lei Wang, Haitao Gu, et al.. (2022). Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips. iScience. 26(1). 105723–105723. 4 indexed citations
5.
Xie, Peiyi, Jiuliang Yan, Hui Li, et al.. (2022). CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis. Annals of Translational Medicine. 10(12). 689–689. 13 indexed citations
6.
Xu, Midie, Jiuliang Yan, Beiyuan Hu, et al.. (2022). Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations. Genes. 13(9). 1588–1588. 3 indexed citations
7.
Chen, Zheng, Shuang Liu, Peiyi Xie, et al.. (2022). Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro. Biochemical and Biophysical Research Communications. 605. 82–89. 21 indexed citations
8.
Hu, Beiyuan, Haitao Gu, Jiuliang Yan, et al.. (2022). Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma. Annals of Translational Medicine. 10(5). 262–262. 51 indexed citations
9.
Chang, Hulin, Lei Jin, Peiyi Xie, et al.. (2022). Complement C5 is a novel biomarker for liver metastasis of colorectal cancer. Journal of Gastrointestinal Oncology. 13(5). 2351–2365. 7 indexed citations
10.
11.
Zhang, Bo, Shuang Liu, Binghai Zhou, et al.. (2021). High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma. Annals of Translational Medicine. 9(1). 17–17. 2 indexed citations
12.
Yan, Jiuliang, Binghai Zhou, Lei Guo, et al.. (2020). GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma.. PubMed. 10(11). 3705–3720. 16 indexed citations
13.
Zhou, Binghai, Jiuliang Yan, Lei Guo, et al.. (2020). Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma. Theranostics. 10(14). 6530–6543. 48 indexed citations
14.
Chen, Zheng, Mincheng Yu, Lei Guo, et al.. (2020). Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation. Frontiers in Oncology. 10. 586820–586820. 14 indexed citations
15.
Yan, Jiuliang, Binghai Zhou, Hui Li, Lei Guo, & Qing‐Hai Ye. (2020). Recent advances of GOLM1 in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 7(2). HEP22–HEP22. 15 indexed citations
16.
Shao, Tuo, Tong Yu, Feifei Su, et al.. (2020). Gamma‐Glutamyltransferase Elevation Is Frequent in Patients With COVID‐19: A Clinical Epidemiologic Study. Hepatology Communications. 4(12). 1744–1750. 22 indexed citations
17.
Zhou, Binghai, Lei Guo, Bo Zhang, et al.. (2019). Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.. PubMed. 9(11). 2442–2455. 71 indexed citations
18.
Ye, Zhipeng, et al.. (2018). Effect of emodin on T cell subsets in NOD mice with NaI‑induced experimental autoimmune thyroiditis. Molecular Medicine Reports. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hechen Huang Breakdown of academic impact, for papers by Yuuki Ohara Breakdown of academic impact, for papers by László Márkász Breakdown of academic impact, for papers by Lorena Carmona‐Rodríguez Breakdown of academic impact, for papers by Denis I. Trufa Breakdown of academic impact, for papers by Kailiang Zhao Breakdown of academic impact, for papers by Guangxi Zhao Breakdown of academic impact, for papers by Lile He Breakdown of academic impact, for papers by Xizi Dai Breakdown of academic impact, for papers by Wenli Diao
Rankless by CCL
2026